Working… Menu

Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma (STRASS2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04031677
Recruitment Status : Recruiting
First Posted : July 24, 2019
Last Update Posted : July 20, 2021
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Anticancer Fund, Belgium
Australia and New Zealand Sarcoma Association
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 21, 2027
Estimated Study Completion Date : April 21, 2028